Shaker Financial Services LLC decreased its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 71.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 52,652 shares of the company’s stock after selling 131,417 shares during the period. Shaker Financial Services LLC’s holdings in BlackRock Health Sciences Term Trust were worth $792,000 at the end of the most recent reporting period.
A number of other large investors also recently bought and sold shares of the stock. CWM LLC grew its stake in shares of BlackRock Health Sciences Term Trust by 25.6% during the 4th quarter. CWM LLC now owns 3,336 shares of the company’s stock valued at $50,000 after buying an additional 680 shares during the period. Brown Lisle Cummings Inc. boosted its holdings in BlackRock Health Sciences Term Trust by 8.8% in the fourth quarter. Brown Lisle Cummings Inc. now owns 50,764 shares of the company’s stock valued at $764,000 after acquiring an additional 4,098 shares during the last quarter. Apollon Wealth Management LLC boosted its holdings in BlackRock Health Sciences Term Trust by 38.2% in the fourth quarter. Apollon Wealth Management LLC now owns 47,095 shares of the company’s stock valued at $709,000 after acquiring an additional 13,012 shares during the last quarter. Spirepoint Private Client LLC purchased a new stake in BlackRock Health Sciences Term Trust during the fourth quarter valued at about $154,000. Finally, Kavar Capital Partners Group LLC purchased a new stake in BlackRock Health Sciences Term Trust during the fourth quarter valued at about $214,000.
BlackRock Health Sciences Term Trust Stock Performance
Shares of NYSE:BMEZ opened at $14.63 on Friday. The business has a 50-day moving average of $14.53 and a two-hundred day moving average of $14.91. BlackRock Health Sciences Term Trust has a 12 month low of $13.40 and a 12 month high of $15.80.
BlackRock Health Sciences Term Trust Announces Dividend
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.
The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.
See Also
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
